                </a></li></ul></div><p><strong>Figure 3.  <span>Differentiation of E-RoSH cells.</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p>
                     <em>In vitro</em> differentiation a) Morphology of E-RoSH2.1 cell culture two weeks after plating E-RoSH2.1 cells on matrigel coated plate, b) The patent E-RoSH2.1 derived tubular structures were labeled with CFDA, a cytoplasmic green fluorescent dye (Molecular Probe, Eugene, OR) and propidium iodide, and viewed by confocal microscopy (left panel).</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p2" name="article1.body1.sec3.sec3.fig1.caption1.p2"></a><p>The tubular structures were incubated with acetylated red fluoresecent diI-labelled LDL (Molecular Probe, Eugene, OR) for 24 hours and counterstained with SYTOX Green™, a green fluorescent nuclear dye (Molecular Probe, Eugene, OR) before analysis by confocal microscopy (right panel). c–e) Immunoreactivity for vWF, Tie-2 and CD34 on sections of E-RoSH2.1 derived tubular structures. vWF immunoreactivity was visualized using HRP-based detection system.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p3" name="article1.body1.sec3.sec3.fig1.caption1.p3"></a><p>Brown precipitates indicate positive staining.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p4" name="article1.body1.sec3.sec3.fig1.caption1.p4"></a><p>The nuclei were stained with Mayer's hematoxylin. CD34 and Tie-2 immunoreactivities were detected using secondary antibodies conjugated with FITC.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p5" name="article1.body1.sec3.sec3.fig1.caption1.p5"></a><p>Nuclei were counterstained with PI. f) Flow cytometry analysis of E-RoSH2.1 cells for endothelial markers before <em>(right panels)</em> and 60 hours after <em>(left panels)</em> induction of differentiation by plating cells on matrigel.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p6" name="article1.body1.sec3.sec3.fig1.caption1.p6"></a><p>Nonspecific fluorescence was determined by incubation of similar cell aliquots with isotype-matched mouse monoclonal antibodies or with secondary antibody alone.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p7" name="article1.body1.sec3.sec3.fig1.caption1.p7"></a><p>g) Gene expression during <em>in vitro</em> differentiation of E-RoSH2.1 cells on matrigel as measured by quantitative RT-PCR analysis.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p8" name="article1.body1.sec3.sec3.fig1.caption1.p8"></a><p>Relative gene expression is normalized against that at time 0 and expressed as a logarithmic function.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p9" name="article1.body1.sec3.sec3.fig1.caption1.p9"></a><p>h) <em>In vivo</em> differentiation. 1×10<sup>5</sup> E-RoSH2.1 cells labeled with Qdot® nanocrystals (655 nm emission) were injected into a ESC-derived teratoma that was induced in SCID mice.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p10" name="article1.body1.sec3.sec3.fig1.caption1.p10"></a><p>Three days later, the mice were euthanized and the tumors were removed.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p11" name="article1.body1.sec3.sec3.fig1.caption1.p11"></a><p>The tumors were fixed in 4% paraformaldehyde and cryosectioned at 20 µm thickness.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p12" name="article1.body1.sec3.sec3.fig1.caption1.p12"></a><p>The sections were assayed for Tie-2 immunoreactivity using rabbit anti-Tie-2 followed by FITC-conjugated goat anti-rabbit antibody, and counterstained with DAPI. i.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p13" name="article1.body1.sec3.sec3.fig1.caption1.p13"></a><p>A typical section of a capillary plexus in the teratoma as viewed by phase contrast microscopy (<em>top left panel</em>), stained with DAPI, a nuclear stain (<em>top right panel</em>), stained with using rabbit anti-Tie-2 (<em>bottom left panel</em>), and cells labelled with Qdot (<em>bottom right panel</em>). ii. Merging of the three fluorescent stains.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p14" name="article1.body1.sec3.sec3.fig1.caption1.p14"></a><p>Yellow fluorescence indicates co-localisation of Qdot and FITC-conjugated antibody.</p>
